Three of the lawmakers tasked with grilling pharmaceutical executives on the development of Covid-19 vaccines also own stock in one or more of the companies, creating potential conflicts of interest.

It felt like an interrogation, as if she were being accused of doing something wrong, of causing the loss of a pregnancy she hadn’t even known about when she arrived at urgent care. She wished she...

Three of the lawmakers tasked with grilling pharmaceutical executives on the development of Covid-19 vaccines also own stock in one or more of the companies, creating potential conflicts of interest.

Rep. John Culberson made a prescient sale to avoid losses when a tiny biotech's stock tanked. The stock was a favorite of several GOP representatives.

The FDA approval of Aduhelm included dozens of undisclosed calls and emails with Biogen and an “inappropriate” level of coordination with the company, investigators found.

TARRYTOWN, N.Y. , Oct. 30, 2020 /PRNewswire/ -- The IDMC also recommends continuation of enrollment in the REGN-COV2 outpatient trial Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) received today a...

Of the 50 companies founded out of Stanford’s Biodesign center, just two have folded. Six were acquired; the rest are "alive and well." The program director shares the secrets behind the success.

Biogen’s quest to win approval for a new Alzheimer’s disease treatment once seemed futile. Now the company is sitting on what could be the most lucrative product in pharmaceutical history.

A University of Pennsylvania team showed a gene-edited pig liver kept alive in a perfusion chamber could support the circulatory system of a human.

The top five executives at Moderna have sold more than $88 million of stock so far this year, as the company’s share price has soared on hopes for its Covid-19 vaccine.

Athletes, politicians, and other wealthy or well-connected people have managed to get special treatment throughout the Covid-19 pandemic. Early access to coronavirus vaccines is likely to be no...

An investigational Alzheimer’s disease treatment from Biogen and Eisai slowed the rate of cognitive decline by 27% in a clinical trial, the companies said Tuesday, meeting the goals of a closely...

Pfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business.

Approval of Biogen’s aducanumab would likely only increase massive racial inequities in the treatment of the more than 6 million Americans with Alzheimer’s.

The clinical trial of a cancer drug rejected by the FDA last week was marked by violations of study rules, investigator misconduct, and signs of toxicity, internal documents obtained by STAT show.

The path from a brilliant discovery to medication can be long. Example A: The long slog to turn the Nobel-winning tech known as RNAi into a drug.

The FDA will hold a public meeting in March to talk with digital health companies about the way it regulates the rapidly changing field, @DrAbernethyFDA told STAT.

A potential Covid-19 vaccine from the biotech company Novavax showed a promising immune response in a small, early trial, but not without a high rate of mostly mild side effects.

The high-profile billionaire has launched the Mark Cuban Cost Plus Drug Company, which its website says is “dedicated to producing low-cost versions of high-cost generic drugs."

OrbiMed Advisors LLC (“OrbiMed” or the “Firm”), a leading investment firm focused on the healthcare sector, today announced that pursuant to years-lon

This week on the "The Readout LOUD," we're spending the entire episode remembering Sharon Begley, our revered and beloved colleague who died last week from complications of lung cancer. Listen now:

Mallinckrodt tentatively agreed to pay $15.4 million to settle illegal marketing charges by Questor, but vowed to fight new claims that Questcor illegally used a charity to pay kickbacks.